<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This study examined the effects of an inhibitor of <z:chebi fb="0" ids="34306">20-hydroxyeicosatetraenoic acid</z:chebi> (<z:chebi fb="0" ids="34306">20-HETE</z:chebi>) synthesis, N-(3-chloro-4-morpholin-4-yl)<z:chebi fb="1" ids="30396">phenyl</z:chebi>-N'-hydroxyimido <z:chebi fb="0" ids="16397">formamide</z:chebi> (TS-011), on <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, volume at risk, cerebral blood flow (CBF), and levels of <z:chebi fb="0" ids="38559">cytochrome P450</z:chebi> (CYP450) <z:chebi fb="0" ids="23899">eicosanoids</z:chebi> in the brain after transient occlusion of the middle cerebral artery (t-MCAO) in rats </plain></SENT>
<SENT sid="1" pm="."><plain>TS-011 (0.1 mg/kg, iv) reduced cortical <z:mpath ids='MPATH_124'>infarct</z:mpath> volume by approximately 70% and total <z:mpath ids='MPATH_124'>infarct</z:mpath> volume by 55% </plain></SENT>
<SENT sid="2" pm="."><plain>TS-011 had no effect on the volume at risk or CBF during or up to 30 mins after the ischemic period </plain></SENT>
<SENT sid="3" pm="."><plain>TS-011 reduced the delayed fall in CBF seen 2 h after reperfusion </plain></SENT>
<SENT sid="4" pm="."><plain>The levels of CYP450 <z:chebi fb="0" ids="23899">eicosanoids</z:chebi> were similar in the ischemic and contralateral hemispheres after t-MCAO </plain></SENT>
<SENT sid="5" pm="."><plain>TS-011 reduced <z:chebi fb="0" ids="34306">20-HETE</z:chebi> levels in cerebral tissue by 80% but had no effect on the levels of EETs </plain></SENT>
<SENT sid="6" pm="."><plain>Administration of another <z:chebi fb="0" ids="34306">20-HETE</z:chebi> inhibitor, HET0016 (0.01 to 1.0 mg/kg, iv) or a <z:chebi fb="0" ids="34306">20-HETE</z:chebi> <z:chebi fb="68" ids="48706">antagonist</z:chebi> 20-hydroxyeicosa-6(Z),15(Z)-dienoic acid (10 mg/kg, iv) also reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> size </plain></SENT>
<SENT sid="7" pm="."><plain>These results indicate that inhibitors of the synthesis or vasoconstrictor effects of <z:chebi fb="0" ids="34306">20-HETE</z:chebi> reduce <z:mpath ids='MPATH_124'>infarct</z:mpath> size in rats after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>The effects of TS-011 are not associated with changes in the area at risk or CBF and may be because of a potential protective effect in neurons subjected to ischemic stress </plain></SENT>
</text></document>